Similarly, improved patient survival and platinum-based chemotherapy TR were observed in cholangiocarcinoma, cervical squamous cell carcinoma, and other tumors with lower ERCC1 levels [44–51]. The gene discussed is ERCC1; the disease is cholangiocarcinoma.